Synthesis of compounds based on the active domain of cabotegravir and their application in inhibiting tumor cells activity
- PMID: 38315083
- PMCID: PMC11230920
- DOI: 10.1002/open.202300284
Synthesis of compounds based on the active domain of cabotegravir and their application in inhibiting tumor cells activity
Abstract
Structural modification based on existing drugs, which ensures the safety of marketed drugs, is an essential approach in developing new drugs. In this study, we modified the structure of cabotegravir by introducing the front alkyne on the core structure through chemical reaction, resulting in the synthesis of 9 compounds resembling 1,2,3-triazoles. The potential of these new cabotegravir derivatives as tumor suppressors in gastrointestinal tumors was investigated. Based on the MTT experiment, most compounds showed a reduction in the viability of KYSE30 and HCT116 cells. Notably, derivatives 5b and 5h exhibited the most significant inhibitory effects. To further explore the effects of derivatives 5b and 5h on gastrointestinal tumors, KYSE30 cells were chosen as a representative cell line. Both derivatives can effectively curtail the migration and invasion capabilities of KYSE30 cells and induce apoptosis in a dose-dependent manner. We further demonstrated these derivatives induce cell apoptosis in KYSE30 cells by inhibiting the expression of Stat3 protein and Smad2/3 protein. Based on the above results, we suggest they show promise in developing drugs for esophageal squamous cell carcinoma.
Keywords: Cabotegravir; ESCC; KYSE30; apoptosis; derivatives.
© 2024 The Authors. ChemistryOpen published by Wiley-VCH GmbH.
Conflict of interest statement
The authors declare no conflict of interest, financial or otherwise, in this paper.
Figures






Similar articles
-
Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1.J Enzyme Inhib Med Chem. 2018 Dec;33(1):1248-1255. doi: 10.1080/14756366.2018.1497019. J Enzyme Inhib Med Chem. 2018. PMID: 30261753 Free PMC article.
-
Structure-based discovery of potent and selective small-molecule inhibitors targeting signal transducer and activator of transcription 3 (STAT3).Eur J Med Chem. 2021 Oct 5;221:113525. doi: 10.1016/j.ejmech.2021.113525. Epub 2021 May 7. Eur J Med Chem. 2021. PMID: 34000483
-
Myricetin exerts anti-proliferative, anti-invasive, and pro-apoptotic effects on esophageal carcinoma EC9706 and KYSE30 cells via RSK2.Tumour Biol. 2014 Dec;35(12):12583-92. doi: 10.1007/s13277-014-2579-4. Epub 2014 Sep 6. Tumour Biol. 2014. PMID: 25192723
-
Design, Synthesis, And Evaluation Of Cyanopyridines As Anti-Colorectal Cancer Agents Via Inhibiting STAT3 Pathway.Drug Des Devel Ther. 2019 Sep 24;13:3369-3381. doi: 10.2147/DDDT.S217800. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31576111 Free PMC article.
-
Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level.Eur J Med Chem. 2024 Jun 5;272:116448. doi: 10.1016/j.ejmech.2024.116448. Epub 2024 Apr 30. Eur J Med Chem. 2024. PMID: 38704936
References
-
- Araghi M., Soerjomataram I., Jenkins M., Brierley J., Morris E., Bray F., Arnold M., Int. J. Cancer 2019, 144 (12), 2992–3000. - PubMed
-
- Sung H., Ferlay J., Siegel R. L., Laversanne M., Soerjomataram I., Jemal A., Bray F., Ca-Cancer J. Clin. 2021, 71 (3), 209–249. - PubMed
-
- Torre L. A., Siegel R. L., Ward E. M., Jemal A., Cancer Epidemiol. Biomarkers Prev. 2016, 25 (1), 16–27. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous